FDA Inspection 1129296 — Myovant Sciences, Inc.
The FDA completed an inspection of Myovant Sciences, Inc. on June 30, 2020 in Brisbane, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 30, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brisbane, CA (United States)
Additional Details
Sponsor, Contract Research Organization